Advertisement

Topics

SUGEN Company Profile

20:28 EDT 25th September 2017 | BioPortfolio

SUGEN is a biopharmaceutical company focused on the discovery and development of small molecule drugs which target specific cellular signal transduction pathways. These signalling pathways are regulated by cell-surface receptors or intracellular signalling molecules known as tyrosine kinases ("TKs"), tyrosine phosphatases ("TPs") and serine-threonine kinases ("STKs"), three of the largest known families of receptors in the body and key regulators of critical cellular functions. Aberrant signalling of TKs, TPs and STKs has been shown to result in a variety of chronic and acute pathological diseases, including cancer and diabetes as well as in dermatologic, ophthalmic, neurologic and immune disorders. The Company believes that compounds designed to target certain kinases and phosphatases and inhibit enzyme activity or prevent the binding of downstream signalling molecules make attractive therapeutic product candidates.

Location

230 E. Grand Ave
South San Francisco
CA
94080
United States of America

Contact

Phone: 650 553 8741
Fax: 650 553 8348


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.

RATIONALE Progression of pulmonary arterial hypertension (PAH) is associated with pathologic remodeling of the pulmonary vasculature and the right ventricle (RV). Oxidative stress drives the remodelin...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

SUGEN

SUGEN is a biopharmaceutical company focused on the discovery and development of small molecule drugs which target specific cellular signal transduction pathways. These signalling pathw...

Cureline, Inc

Cureline is a global biosample management company providing effective solutions for human tissue acquisition and related histology services. It was founded by a group of scientists and business develo...

Argus Biosciences LLC

Argus Biosciences was founded in 2003 by Dr. David Whyte.Dr. Whyte received his Ph.D. in Molecular Biology from the University of California, San Francisco, and has a Bachelors of Science degree in Ch...

More Information about "SUGEN" on BioPortfolio

We have published hundreds of SUGEN news stories on BioPortfolio along with dozens of SUGEN Clinical Trials and PubMed Articles about SUGEN for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SUGEN Companies in our database. You can also find out about relevant SUGEN Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record